InflaRx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of InflaRx using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.21 | $-0.19 | -10.5 % |
| Q2 | 2025-08-07 | $-0.24 | $-0.24 | 0.00 % |
| Q1 | 2025-05-07 | $-0.14 | $-0.17 | 17.6 % |
| Q4 | 2025-03-20 | $-0.09 | $-0.28 | 67.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $27.86K | $230.00K | -87.9 % |
| Q2 | 2025-08-07 | $44.71K | $120.00K | -62.7 % |
| Q1 | 2025-05-07 | $0 | $34.33K | -100.0 % |
| Q4 | 2025-03-20 | $-451.46K | $125.00K | -461.2 % |
InflaRx (IFRX) is scheduled to report earnings on March 19, 2026. The last reported earnings were for reported on November 10, 2025 for Q3.
The Actual EPS was $-0.21, which missed the estimate of $-0.19.
The Actual Revenue was $27.9K, which missed the estimate of $230K.
Browse earnings estimates, EPS, and revenue on all stocks.